Genef China News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Business Wire. The AP news staff was not involved in its creation.
GC Pharma Reports Full Year 2020 Results
February 9, 2021 GMT
YONGIN, South Korea (BUSINESS WIRE) Feb 9, 2021
GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited financial results for the year ended 31 December 2019.
Key Figures (1)
-
(1) Results from continuing operations (Green Cross MS’ blood bag business has been classified as discontinued operations)
(2) Results and percentages compare full financial year 2019
Financial Highlights
Delivered total revenue growth of 10.8% to KRW 1,504.1 billion (2019: 1,357.1 billion), and operation profit increased 20.6% to KRW 50.2 billion (2019: 41.7 billion) in the full year of 2020 ....

United States , South Korea , South Korean , Hyungoo Kang , Woosub Shin , Cross Labcell , Green Cross Corporation , Green Cross , Genef China , Cross Corporation , Business Wire , Corporate News , Pharmaceutical Manufacturing , Health Care Industry , East Asia , Earnings Reports , Medical Biotechnology Industry , Financial Performance , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , தெற்கு கொரியன் , பச்சை குறுக்கு நிறுவனம் , பச்சை குறுக்கு , குறுக்கு நிறுவனம் , வணிக கம்பி , பெருநிறுவன செய்தி ,